Logos
Crossover fundActively deployingSan Francisco · Series A–Series B · 15 people tracked
Also known as LOGOS GLOBAL MANAGEMENT, L.P. · Logos Odin
Investment thesis
Logos Capital invests in biotechnology with a disciplined, data-driven and research-intensive approach, aiming to identify transformative, first-in-class and best-in-class therapeutics at attractive valuations. Recognizing that success in biotech requires more than science, the firm integrates clinical underwriting, continuous event tracking, and proactive risk management to assess intrinsic value across clinical, operational, regulatory, and commercial dimensions. It targets technologies that advance patient care through functional cures, improved access, and extended life expectancy. A proprietary data science platform, Logos Analytics, supports evaluation of trial design and probability of clinical success, with the primary mandate of delivering strong long-term returns to investors.
Source: firm website, verified Aug 3, 2026.
Team · 15 people
from the firm's website & public directoriesWhat they invest in
from 1 of 1 portfolio companiesBiotech ×1
HQs:China×1
Investments · 1 tracked
founders shown can be your intro pathNiKang Therapeutics is a clinical-stage biotech company developing small molecule drugs for cancer treatment, focusing on HIF2α, CDK2, and KRAS targets using structure-based drug design.
Biotech
Frequently asked questions
- What stage does Logos invest at?
- Logos invests at the Series A, Series B stages.
- What sectors does Logos focus on?
- Logos focuses on Biotech, Digital Health, Healthtech.
- Where is Logos located?
- Logos is headquartered in San Francisco, US.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Bessemer Venture Partners is a venture capital firm that partners with entrepreneurs from early stages through every stage of growth, publishing investment roadmaps across multiple technology sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.












